Published in Fertil Steril on September 01, 1991
The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol Cell Biol (1994) 1.48
Antioxidant: a new role for RU-486 and related compounds. J Clin Invest (1994) 0.88
Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486. J Psychiatry Neurosci (1993) 0.86
Antiprogestins in gynecological diseases. Reproduction (2014) 0.78
Estradiol and progesterone-induced slowing of gonadotropin-releasing hormone pulse frequency is not reversed by subsequent administration of mifepristone. Endocrine (2009) 0.77
RU 486 (mifepristone). West J Med (1992) 0.75
Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature (1990) 4.70
Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest (2001) 3.79
Systemic anticancer therapy in gynecological cancer patients with renal dysfunction. Int J Gynecol Cancer (2007) 2.71
PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol Cell Biol (1994) 2.68
Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue. A large-scale French experience. N Engl J Med (1990) 2.66
A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med (1986) 2.18
Postcoital contraception: myth or reality? Lancet (1991) 2.16
Muscle postjunctional membrane: changes in chemosensitivity produced by calcium. Science (1966) 2.12
Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist. Fertil Steril (1993) 2.09
Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med (1993) 2.00
Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule. Proc Natl Acad Sci U S A (2001) 1.92
A dimeric crystal structure for the N-terminal two domains of intercellular adhesion molecule-1. Proc Natl Acad Sci U S A (1998) 1.91
The polycystic ovary syndrome. Clin Endocrinol (Oxf) (1980) 1.84
Premenstrual syndrome. Am J Obstet Gynecol (1981) 1.80
RU486 (mifepristone): mechanisms of action and clinical uses. Annu Rev Med (1997) 1.80
Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab (1994) 1.79
Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors. Cell (1999) 1.75
Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience. Jpn J Clin Oncol (2000) 1.74
Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab (1974) 1.73
A simple method for the assay of eight steroids in small volumes of plasma. Steroids (1976) 1.69
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Pulsatile ocular blood flow in asymmetric exudative age related macular degeneration. Br J Ophthalmol (2001) 1.66
The effect of conjugated equine oestrogen on diabetes incidence: the Women's Health Initiative randomised trial. Diabetologia (2006) 1.65
Pulsatile patterns of gonadotropin release in subjects with and without ovarian function. J Clin Endocrinol Metab (1972) 1.59
Function of apoptosis and expression of the proteins Bcl-2, p53 and C-myc in the development of gastric cancer. World J Gastroenterol (2001) 1.59
Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest (1976) 1.58
Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: the calendar of premenstrual experiences. Obstet Gynecol (1990) 1.58
Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease. J Clin Endocrinol Metab (1970) 1.57
Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology (1999) 1.57
Pattern of increase in circulating prolactin levels during human gestation. Am J Obstet Gynecol (1977) 1.56
Early renal changes in hemizygous and heterozygous patients with Fabry's disease. Kidney Int (1978) 1.56
Evidence for a hypothalamic site of action of clomiphene citrate in women. J Clin Endocrinol Metab (1985) 1.54
Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia. Blood (1998) 1.52
Structural basis of CD8 coreceptor function revealed by crystallographic analysis of a murine CD8alphaalpha ectodomain fragment in complex with H-2Kb. Immunity (1998) 1.51
Treatment of endometriosis with the antiprogesterone mifepristone (RU486) Fertil Steril (1996) 1.48
Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropin in man. J Clin Endocrinol Metab (1968) 1.48
The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol (Oxf) (1998) 1.45
Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks. Hum Reprod (1999) 1.45
Pituitary apoplexy. A review. Arch Neurol (1985) 1.44
Cloning of a human ether-a-go-go potassium channel expressed in myoblasts at the onset of fusion. FEBS Lett (1998) 1.43
Variation of pituitary responsiveness to synthetic LRF during different phases of the menstrual cycle. J Clin Endocrinol Metab (1972) 1.42
Hepres genitalis; clinical and cytopathologic experience with 256 patients. Obstet Gynecol (1970) 1.42
Orotracheal to nasotracheal tube exchange in children. Minerva Anestesiol (2010) 1.39
Obstetrics and gynecology-epitomes of progress: a new and effective treatment of hirsutism. West J Med (1981) 1.39
Hormonal dynamics at midcycle: a reevaluation. J Clin Endocrinol Metab (1983) 1.39
Peripapillary fluorescein leakage in 11778 Leber's optic neuropathy. J Neuroophthalmol (1996) 1.37
Idiopathic premature ovarian failure: clinical and endocrine characteristics. Fertil Steril (1982) 1.36
Characterization of a gene family encoding abscisic acid- and environmental stress-inducible proteins of alfalfa. J Biol Chem (1992) 1.36
Chronological changes in sex steroid, gonadotropin and prolactin secretions in aging female rats displaying different reproductive states. Biol Reprod (1979) 1.35
Treatment of hirsutism with spironolactone. JAMA (1982) 1.34
Crystal structure of ICAM-2 reveals a distinctive integrin recognition surface. Nature (1997) 1.34
T-type alpha 1H Ca2+ channels are involved in Ca2+ signaling during terminal differentiation (fusion) of human myoblasts. Proc Natl Acad Sci U S A (2000) 1.33
Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metab (1996) 1.29
Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol (1974) 1.29
Increased interleukin-6 in aqueous humor of neovascular glaucoma. Invest Ophthalmol Vis Sci (1999) 1.26
Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab (1992) 1.26
Distribution of the tandem repeat sequences and karyotyping in cucumber (Cucumis sativus L.) by fluorescence in situ hybridization. Cytogenet Genome Res (2008) 1.26
The functional changes of the pituitary gonadotrophs during the menstrual cycle. J Clin Endocrinol Metab (1976) 1.25
Alterations in the hypothalamic-pituitary-ovarian and the hypothalamic-pituitary-adrenal axes in athletic women. J Clin Endocrinol Metab (1989) 1.25
Gonadotropin-releasing hormone pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins. J Clin Endocrinol Metab (1993) 1.23
Inhibition of growth hormone release in humans by somatostatin. J Clin Endocrinol Metab (1973) 1.22
Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity. J Clin Endocrinol Metab (1997) 1.22
Macular subretinal neovascularization in choroidal tuberculosis. Ann Ophthalmol (1989) 1.21
Termination of early pregnancy by the progesterone antagonist RU 486 (Mifepristone). N Engl J Med (1986) 1.21
The estimation of pituitary luteinizing hormone secretion. J Clin Endocrinol Metab (1973) 1.21
Melatonin: a major regulator of the circadian rhythm of core temperature in humans. J Clin Endocrinol Metab (1992) 1.20
Pathogenesis and neuroprotective treatment in Purtscher's retinopathy. Jpn J Ophthalmol (1998) 1.19
Neuroendocrinology of menopausal flushes: an hypothesis of flush mechanism. Clin Endocrinol (Oxf) (1985) 1.19
Menopausal flushes: a neuroendocrine link with pulsatile luteninizing hormone secreation. Science (1979) 1.16
Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia. J Clin Endocrinol Metab (1997) 1.16
Regression of uterine leiomyomata in response to the antiprogesterone RU 486. J Clin Endocrinol Metab (1993) 1.15
Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. Endocrinology (1981) 1.15
Activation of nicotinic acetylcholine receptors increases the rate of fusion of cultured human myoblasts. J Physiol (1995) 1.14
Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect. Fertil Steril (1995) 1.14
Hypoleptinemia in women athletes: absence of a diurnal rhythm with amenorrhea. J Clin Endocrinol Metab (1997) 1.13
Induction of ovulation and pregnancy with pulsatile luteinizing hormone releasing factor: dosage and mode of delivery. Fertil Steril (1981) 1.13
Modification of circadian body temperature rhythm during the luteal menstrual phase: role of melatonin. J Appl Physiol (1985) (1996) 1.12
Ectopic pregnancy. Clin Obstet Gynecol (1991) 1.11
Identification of a common docking topology with substantial variation among different TCR-peptide-MHC complexes. Curr Biol (1998) 1.11
Acute suppression of circulating testosterone levels by cortisol in men. J Clin Endocrinol Metab (1983) 1.11
Gonorrhea during pregnancy. Obstet Gynecol (1968) 1.10
Circulating estradiol, estrone and gonadotropin levels following the administration of orally active 17beta-estradiol in postmenopausal women. J Clin Endocrinol Metab (1975) 1.09
Release of prostaglandins and histamine from sensitized and anaphylactic guinea pig lungs--changes in cyclic AMP levels. Biochem Pharmacol (1977) 1.09
Gonadotropin dynamics in patients with gonadal dysgenesis: a model for the study of gonadotropin regulation. J Clin Endocrinol Metab (1972) 1.09
The biology of menopause. J Reprod Med (1977) 1.09
Comparative genomic hybridization of esophageal squamous cell carcinoma: correlations between chromosomal aberrations and disease progression/prognosis. Cancer (2001) 1.08
Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography. Acta Ophthalmol Scand (2001) 1.08
beta-Endorphin in the human pancreas. J Clin Endocrinol Metab (1979) 1.08
Effects of maternal smoking on circulating catecholamine levels and fetal heart rates. Am J Obstet Gynecol (1979) 1.08
Critical role of Lyn kinase in inhibition of neutrophil apoptosis by granulocyte-macrophage colony-stimulating factor. J Immunol (1996) 1.07
Release of prostaglandins from healthy and sensitized guinea-pig lung and trachea by histamine. Prostaglandins (1976) 1.07
Search for stopped Gluinos in pp collisions at square root s=7 TeV. Phys Rev Lett (2011) 1.07
Modulation of pituitary responsiveness to LRF by estrogen. J Clin Endocrinol Metab (1974) 1.07
Evidence for an increased opioid inhibition of luteinizing hormone secretion in hyperprolactinemic patients with pituitary microadenoma. J Clin Endocrinol Metab (1980) 1.06